Objective: The prevalence of β-thalassemia in Şanlıurfa province, Turkey is reported to be 2.6%-3.7%, whereas nation-wide the frequency of β-thalassemia is 2%. This study aimed to identify the most frequent β-thalassemia mutations in Şanlıurfa province. Materials and Methods: In total, 22 mutations were investigated in 115 pediatric patients with β-thalassemia using a commercially available reverse dot blot platform. Results: The study included 60 male and 55 female patients with a mean age of 7.3±4.6 years (range: 1-17 years). In total, 76% of the patients had consanguineous parents. In all, 16 different mutations were observed in the 115 patients. IVS-1-110 (G-A) (29.1%), IVS-1-1 (G-A) (13.9%), codon 39 (C>T) (10.4%), and codon 8 (-AA) (9.1%) accounted for 62.5% of all the β-thalassemia mutations, and 6% of the patients had 2 different thalassemia mutations. According to the present results, IVS-1-110 (G>A) was the most frequent mutation observed in the patients from Şanlıurfa province, as in other geographical regions of Turkey. In addition, the following 34 compound heterozygote mutant alleles were observed; IVS-1-1 (G>A)/IVS 2. Province. The present findings may be of value for genetic counseling, and premarital and prenatal diagnosis in Şanlıurfa province. (Turk J Hematol 2011; 28: 264-8) 
Introduction
Although β-thalassemia is associated with >200 mutations, most are rare [1] . Approximately 20 common alleles constitute 80% of all known thalassemias worldwide; 3% of the world's population carries genes for β-thalassemia. The overall frequency of β-thalassemia in Turkey is 2%, but within the country the rate differs significantly according to region. In particular areas of the country there are fewer common alleles. The highest frequencies of β-thalassemia in Turkey are observed in Antalya, Thrace (10% each), and Muğla (4.8%) [2] . The frequency of β-thalassemia in Turkey is lowest in eastern and northern Anatolia, and is moderate in southern Anatolia.
β-thalassemia mutations are extremely heterogeneous [2] [3] [4] [5] . It was reported that only 7 mutations comprise 67% of all β-thalassemia mutations [6, 7] . Regional differences in the frequency of various mutations may offer clues regarding migration patterns and the ethnic background of a particular population [3, 6] . It was previously reported that IVS-1-110 (G-A), codon 8 (-AA), and IVS-2-1 (G>A) mutations were present in 28 of 51 patients with β-thalassemia in Şanlıurfa Province, Turkey [8] . The present study aimed to determine the prevalence of 22 mutations in 115 patients with β-thalassemia from Şanlıurfa Province, Turkey, and which occurred most frequently.
Materials and Methods
This study was conducted at Harran University, Education and Research Hospital, Pediatric Hematology outpatient clinic between March and May 2010. The study included 115 patients (60 male and 55 female) with a mean age of 7.3±4.6 years (range: 1-17 years). The Harran University Education and Research Hospital Ethics Committee approved the study protocol, and written informed consent was obtained from all the patients' parents.
Blood samples were collected from the β-thalassemia patients into EDTA tubes and brought to the laboratory in a cold chain. The place and date of birth, and the name of each patient were recorded. Hematological analysis was performed the same day blood was collected using an automated cell counter (Cell Dyne 1700, Abbott Diagnostics). DNA was isolated via standard phenol-chloroform extraction and ethanol precipitation, and mutation analysis of the β-globin gene was performed using a commercially available reverse dot blot platform (Beta-Globin Strip Assay, Vienna Lab, Vienna, Austria). Mutations affecting gene transcription were -101 (C>T), -87 (C>G), and -30 (T>A), frame- shift types of premature termination (nonsense) mutation were codon 5 (-CD), codon 6 (-A), codon 6 (G>A) HbC, codon 6 (A>T) HbS, codon 8 (-AA), codon 8/9 (+G), and codon 44 (-C), substitution types were codon 15 (G>A) and codon 39 (C>T), the exon processing type of RNA splicing mutation was codon 27 (G>T) Hb Knossos, the splice junction change in the 5' donor site was IVS-1-1 (G>A), splice consensus sequence changes in the 5' donor site were IVS-1-5 (G>A), IVS-1-6 (T>C), and IVS-2-1 (G>A), mutations within exons that affect processing internal IVS change were IVS-1-110 (G>A) and IVS-2-745 (C>G), the splice junction change in the 3' acceptor site was IVS-1-130 (G>C), the internal IVS change was IVS-1-116 (T>G), and the splice consensus sequence change in 3' acceptor site was IVS-2-848 (C>A) [9] .
Results
In all, 22 mutations were investigated in 115 pediatric patients with β-thalassemia. Whereas 74 of patients were not related, 41 were brothers and/or sisters. In total, 16 different mutations in 208 alleles were identified, and IVS-1-110 (G-A) (29.1%), IVS-1-1 (G>A) (13.9%), codon (39 (C>T) (10.4%), and codon 8 (-AA) (9.1%) accounted for 62.5% of all the β-thalassemia mutations (Table 1) . IVS-1-110 (G>A) was the most frequent mutation type in the patients from Şanlıurfa Province, as in other geographic regions of Turkey. In all, 76% of the patients had consanguineous parents; 65% of these consanguineous marriages were between first cousins. β-thalassemia mutations were homozygous in 71.3% of the patients, heterozygous in 10.4%, compound heterozygous in 4.8%, and undetermined in 9.6%.
In addition, the following 34 compound heterozygote mutant alleles were observed; IVS-1-1 (G>A)/ IVS-2-848 (n=4), codon 39 (C>T)/codon 8 (-AA) (n=2), codon 6 (-A)/IVS-1-5 (G>C) (n=2), IVS-1-110 (G>A)/IVS-1-1 (G>A) (n=2), IVS-1-110 (G>A)/ codon 8 (-AA) (n=1), IVS-1-110 (G>A)/codon 39 (C>T) (n=1), IVS-1-110 (G>A)/IVS-1-6 (T>C) (n=1), IVS-1-110 (G>A)/IVS-1-5 (G>C) (n=1), IVS-1-110 (G>A)/codon 8/9 (+G) (n=1), IVS-1-1 (G>A)/ codon 39 (C>T) (n=1), and codon 8 (-AA)/IVS-1-5 (G>C) (n=1) ( Table 2 ). The following β-thalassemia mutations were not observed; -101 (C>T), -87 (C>T), -30 (T>A), codon 15 (TTG>TGA), codon 27 (G>T) Knossos, and VS-1-116 (T>G). 
Discussion
β-thalassemia is a serious medical, social, and economic problem, both for affected families and the general population. To the best of our knowledge all published studies related to β-thalassemia mutations are concerned with thalassemia carrier status [3] [4] [5] , and only 2 mutations in children with β-thalassemia [8] ; as such, the present study is the first to examine 22 thalassemia mutations in 115 children with β-thalassemia from Şanlıurfa Province, Turkey.
Based on a comparison of the frequency of several mutations, IVS-1-110 (G-A) is the most common mutation in Syria, Macedonia, Greece, and Bulgaria, as in the present study (29%), which is nearly half the rate previously reported for Turkey [2] . The IVS-1-1 (G-A) mutation, which is highly prevalent in the Marmara and Aegean regions of Turkey, is among the 4 most common mutations in Mediterranean and Middle Eastern countries [8] ; in the present study it was the 2 nd most common mutation (14%). The order of frequency for other mutations, however, is different [2, 10, 11] . There are some differences between the frequency of mutations observed in Şanlıurfa in the present study and that in the nearest provinces Gaziantep and Diyarbakir, e.g. the frequency of codon 39 (C>T) was 10.3%, 3.6%, and 6.4%, respectively [13] .
It was reported that -30 (T>A) mutation, which is more common in eastern and southeastern Anatolia than other regions [8, 12] , but its frequency is similar to Iran and Syria, was not identified in any mutant allele in Şanlıurfa, a large city in southeastern Anatolia. IVS-2-1 (G>A) and codon 8 (-AA) are both β-thalassemia mutations associated with mild thalassemia, and are the 2 most common mutations in Azerbaijan [3] . Patients in the present study that had these mutations did not have mild thalassemias, and codon 8 (-AA) mutation was the 3 rd most common mutation we observed. IVS-1-130 (G>C) mutations are seen exclusively in patients originating from the city of Burdur in the Mediterranean Region of Turkey and have not been reported from any other country [2] .
In the present study IVS-1-130 (G>C) mutations were noted in 6 homozygous alleles. The present findings illustrate the heterogeneity of β-thalassemia mutations in Şanlıurfa Province, as in other cities in Turkey [2] . A broad range of mutations have been observed in Turkey, probably because of its location at the convergence of 3 continents and the subsequent influence of various ethnic groups [13] . The consanguineous marriage rate observed among the parents of the patients in the present study was 76%, which is higher than previously reported [5] , whereas the prevalence of compound heterozygous β-thalassemia mutations was lower (6%).
Turkey has had a national hemoglobinopathy screening program since 2002, known as the Fight against Hereditary Blood Disease [14] . The program's guidelines were developed for the prevention and treatment of hemoglobinopathies. It is estimated that 150-200 infants will be born with β-thalassemia annually in Turkey [15] . Özdemir et al. reported that premarital screening and prenatal diagnosis are quite successful in preventing the birth of children with thalassemia major in Muğla, Turkey [16] . During such screening 131 at-risk couples were identified and those at risk of having children with hemoglobinopathy were referred for prenatal diagnosis. In all, 75 mothers underwent prenatal diagnosis and 21 were diagnosed with beta thalassemia major; in all the cases pregnancy was terminated in Muğla [16] . Since the start of premarital screening in Muğla, there have been no new β-thalassemia major births [16] . Conversely, a study on the efficacy of premarital screening in Hatay, Turkey, showed that only 17.5% of pregnant highrisk couples underwent prenatal diagnosis, despite receiving genetic counseling [17] . These results show that effectiveness of education in the hemoglobinopathy prevention program is inefficient in some province [15] . To the best of our knowledge no study related to the effect of Turkey's hemoglobinopathy screening program on the rate of children born with thalassemia has been published.
Controls of new thalassemic cases can be achieved in higher difficulties in Şanlıurfa Province, because of the presence of different ethnic groups that have large and young families, low socioeconomic and educational status, and as high as 65% close consanguineous and common-law marriages. Unfortunately, many at-risk couples still discover their risk only after giving birth to an affected child. In addition, at-risk couples find it very difficult to opt for abortion after learning that their fetus has β-thalassemia major or other severe diseases. In the Ayçiçek et Hematol 2011; 28: 264-8 present study mean age of the patients was 7.3±4.6 years; in all, 53% of the patients were younger than 8 years and were born after Turkey's hemoglobinopathy screening program began.
Turkey's hemoglobinopathy screening program must take into account epidemiological and molecular data to set up the adequate strategy that sensitization and information about the disease, population screening and genetic counseling for carriers, and prenatal diagnosis for couples with affected children. In conclusion, we think that after having identified the most frequent mutations in β-thalassemia patients from Şanlıurfa Province, the frequency of premarital, preconception, and prenatal diagnosis will increase.
